An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)
Clinical trial NCT02365623 · COMPLETED
Trial details
- NCT number
- NCT02365623
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-18
- Primary completion
- 2018-11-08
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.